JP2023531185A5 - - Google Patents
Info
- Publication number
- JP2023531185A5 JP2023531185A5 JP2022577477A JP2022577477A JP2023531185A5 JP 2023531185 A5 JP2023531185 A5 JP 2023531185A5 JP 2022577477 A JP2022577477 A JP 2022577477A JP 2022577477 A JP2022577477 A JP 2022577477A JP 2023531185 A5 JP2023531185 A5 JP 2023531185A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- sequence
- nos
- antibody fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063040894P | 2020-06-18 | 2020-06-18 | |
| US63/040,894 | 2020-06-18 | ||
| US202163166062P | 2021-03-25 | 2021-03-25 | |
| US63/166,062 | 2021-03-25 | ||
| PCT/US2021/037364 WO2021257525A1 (en) | 2020-06-18 | 2021-06-15 | Conditionally active anti-nectin-4 antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023531185A JP2023531185A (ja) | 2023-07-21 |
| JP2023531185A5 true JP2023531185A5 (https=) | 2024-06-18 |
Family
ID=79268274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022577477A Pending JP2023531185A (ja) | 2020-06-18 | 2021-06-15 | 条件的に活性な抗ネクチン４抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230235054A1 (https=) |
| EP (1) | EP4168453A4 (https=) |
| JP (1) | JP2023531185A (https=) |
| KR (1) | KR20230038711A (https=) |
| CN (1) | CN115768798A (https=) |
| AU (1) | AU2021293183A1 (https=) |
| CA (1) | CA3182395A1 (https=) |
| IL (1) | IL298903A (https=) |
| MX (1) | MX2022016192A (https=) |
| TW (1) | TWI901704B (https=) |
| WO (1) | WO2021257525A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4096717B1 (en) | 2020-01-31 | 2024-12-11 | Innate Pharma | Treatment of cancer |
| MX2023005873A (es) * | 2020-11-25 | 2023-06-05 | Innate Pharma | Tratamiento del cancer. |
| KR20240026496A (ko) * | 2021-06-29 | 2024-02-28 | 엘피스 바이오파마슈티컬즈 | 항-넥틴4 항체 및 이를 포함하는 다중특이적 단백질 복합체 |
| EP4463483A4 (en) * | 2022-01-12 | 2025-05-21 | Navi Bio-Therapeutics, Inc. | ANTIBODY SPECIFIC TO NECTIN CELL ADHESION MOLECULE 4 AND USES THEREOF |
| CN116063498A (zh) * | 2022-04-27 | 2023-05-05 | 博际生物医药科技(杭州)有限公司 | 单域抗Nectin-4抗体 |
| WO2024012541A1 (zh) * | 2022-07-14 | 2024-01-18 | 百奥泰生物制药股份有限公司 | 抗Nectin-4抗体药物偶联物及应用 |
| WO2024012536A1 (zh) * | 2022-07-14 | 2024-01-18 | 百奥泰生物制药股份有限公司 | 抗Nectin-4抗体、其抗体药物偶联物及应用 |
| EP4688851A1 (en) | 2023-03-27 | 2026-02-11 | LAVA Therapeutics N.V. | Nectin-4 binding agents and methods of use |
| EP4438624A1 (en) | 2023-03-27 | 2024-10-02 | LAVA Therapeutics N.V. | Antibodies that bind nectin-4 and gamma-delta t cell receptors |
| TW202530249A (zh) * | 2023-09-29 | 2025-08-01 | 美商雅克提斯腫瘤學公司 | 小蛋白、結合物及其用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3803790B2 (ja) * | 2003-02-17 | 2006-08-02 | 株式会社東北テクノアーチ | 新規なダイアボディ型二重特異性抗体 |
| US20110301056A1 (en) * | 2008-12-12 | 2011-12-08 | Oncotherapy Science, Inc. | Nectin-4 for target genes of cancer therapy and diagnosis |
| MX347954B (es) * | 2010-09-29 | 2017-05-19 | Agensys Inc | Conjugados de anticuerpo farmaco (adc) que enlazan a proteinas 191p4d12. |
| EP3347048B1 (en) * | 2015-09-09 | 2020-04-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antibodies having specificity to nectin-4 and uses thereof |
| WO2017078839A1 (en) * | 2015-11-02 | 2017-05-11 | Bioatla, Llc | Conditionally active polypeptides |
| AU2017320874B2 (en) * | 2016-08-31 | 2024-03-07 | Bioatla, Llc | Conditionally active polypeptides and methods of generating them |
| WO2018226578A1 (en) * | 2017-06-05 | 2018-12-13 | Agensys, Inc. | Nectin-4-binding proteins and methods of use thereof |
| KR102892725B1 (ko) * | 2018-05-09 | 2025-12-01 | 이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. | 인간 넥틴4에 특이적인 항체 |
| WO2019241216A1 (en) * | 2018-06-14 | 2019-12-19 | Bioatla, Llc | Multi-specific antibody constructs |
-
2021
- 2021-06-15 CN CN202180043514.3A patent/CN115768798A/zh active Pending
- 2021-06-15 EP EP21826366.3A patent/EP4168453A4/en active Pending
- 2021-06-15 CA CA3182395A patent/CA3182395A1/en active Pending
- 2021-06-15 KR KR1020237002055A patent/KR20230038711A/ko active Pending
- 2021-06-15 IL IL298903A patent/IL298903A/en unknown
- 2021-06-15 AU AU2021293183A patent/AU2021293183A1/en active Pending
- 2021-06-15 JP JP2022577477A patent/JP2023531185A/ja active Pending
- 2021-06-15 MX MX2022016192A patent/MX2022016192A/es unknown
- 2021-06-15 WO PCT/US2021/037364 patent/WO2021257525A1/en not_active Ceased
- 2021-06-15 US US18/002,064 patent/US20230235054A1/en active Pending
- 2021-06-18 TW TW110122293A patent/TWI901704B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023531185A5 (https=) | ||
| JP7685095B2 (ja) | 多重特異性抗体とその作製及び使用方法 | |
| JP2022101693A5 (https=) | ||
| Hong et al. | Chemoenzymatic Synthesis of a Rhamnose‐Functionalized Bispecific Nanobody as a Bispecific Antibody Mimic for Cancer Immunotherapy | |
| JP2021527431A5 (https=) | ||
| JP7399852B2 (ja) | 多重特異性抗体とその作製及び使用方法 | |
| JP2021530987A5 (https=) | ||
| JP2020502271A5 (https=) | ||
| RU2019138067A (ru) | Биспецифическое антитело против ox40 и ctla-4 | |
| JP2017535257A5 (https=) | ||
| CN106659779A (zh) | 双特异性四价抗体及其制造和使用方法 | |
| IL291545B1 (en) | Anti-CTLA4 antibodies, antibody fragments, immunoconjugates thereof and uses thereof | |
| JP2019524640A5 (https=) | ||
| JP2022553922A5 (https=) | ||
| JP2019512207A5 (https=) | ||
| US12053530B2 (en) | Plectin-1 binding antibodies and uses thereof | |
| JP2024542192A5 (https=) | ||
| JP2023502876A5 (https=) | ||
| JP2024508749A (ja) | クローンｔ細胞増殖を処置するための方法および材料 | |
| JP2020533002A5 (https=) | ||
| JP2023511403A5 (https=) | ||
| JP2025506248A5 (https=) | ||
| US20250034252A1 (en) | Manabodies targeting p53 tumor antigens and methods of using | |
| JP2023531189A5 (https=) | ||
| CN119677777A (zh) | 抗cd28抗体 |